Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TKNO is expected to report earnings to fall 3.55% to -10 cents per share on May 07
Q1'25
Est.
$-0.11
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.03
The last earnings report on March 04 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 161.51K shares outstanding, the current market capitalization sits at 108.10M.